Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer

scientific article published on 06 September 2018

Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/14728222.2018.1512587
P698PubMed publication ID30114962

P50authorDaniela LoessnerQ38544906
Peter GoettigQ58229140
Judith ClementsQ17523861
P2093author name stringJulia Dorn
Viktor Magdolen
Holger Bronger
Sarah Preis
Johanna Felber
P2860cites workEvaluating cell lines as tumour models by comparison of genomic profilesQ37025950
P433issue9
P921main subjectovarian cancerQ172341
P304page(s)745-763
P577publication date2018-09-06
P1433published inExpert Opinion on Therapeutic TargetsQ5421214
P1476titleKallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer
P478volume22

Reverse relations

cites work (P2860)
Q64097461Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients
Q97539581High levels of KLK7 protein expression are related to a favorable prognosis in triple-negative breast cancer patients
Q90620494Identification of potential biomarkers and pivotal biological pathways for prostate cancer using bioinformatics analysis methods
Q64910062NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer-An Integrative Multi-Omics Approach.